Incyte Z Score

INCY -  USA Stock  

USD 66.73  1.72  2.65%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Please see Incyte Corp Piotroski F Score and Incyte Corp Valuation analysis.

Incyte Z Score 

 
Refresh
Capital Expenditure is likely to drop to about (192.3 M) in 2021. Return on Invested Capital is likely to drop to -0.24 in 2021. Incyte Corp Direct Expenses is fairly stable at the moment as compared to the past year. Incyte Corp reported Direct Expenses of 131.33 Million in 2020. Cost of Revenue is likely to rise to about 141.7 M in 2021, whereas Consolidated Income is likely to drop (303.5 M) in 2021.

Incyte Z Score Analysis

Incyte Corp's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2018 2019 2020 2021 (projected)
Receivables307.6 M308.81 M481.99 M520.05 M
Inventories6.97 M11.4 M16.43 M17.72 M
Z Score 
 = 
Sum Of  
 
5 Factors 
More About Z Score | All Equity Analysis
First Factor
 = 
1.2 * (
Working Capital
/
Total Assets )
Second Factor
 = 
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
 = 
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
 = 
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
 = 
0.99 * (
Revenue
/
Total Assets )

Incyte Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Incyte Corp is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Incyte Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Incyte Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Incyte Corp's interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

According to the company's disclosures, Incyte Corp has a Z Score of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The z score for all United States stocks is 100.0% higher than that of the company.

Incyte Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Incyte Corp's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Incyte Corp could also be used in its relative valuation, which is a method of valuing Incyte Corp by comparing valuation metrics of similar companies.
Incyte Corp is currently under evaluation in z score category among related companies.

Incyte Corp Current Valuation Drivers

We derive many important indicators used in calculating different scores of Incyte Corp from analyzing Incyte Corp's financial statements. These drivers represent accounts that assess Incyte Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Incyte Corp's important valuation drivers and their relationship over time.
201620172018201920202021 (projected)
Net Income Per Employee106.06 K(259.22 K)80.1 K306.94 K(166.32 K)(170.7 K)
Revenue Per Employee1.13 M1.27 M1.38 M1.48 M1.5 M1.21 M
Average Assets1.43 B1.98 B2.47 B3.09 B3.21 B3.46 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA155.94 M(298.29 M)149.19 M520.75 M(157.64 M)(161.79 M)
Earnings Before Interest Taxes and Depreciation Amortization USD204.57 M(253.21 M)171.86 M543.18 M(178.24 M)(182.93 M)
Earnings before Tax107.4 M(312.29 M)115.35 M486.79 M(232.22 M)(238.33 M)
Average Equity328.57 M1.35 B1.77 B2.34 B2.32 B2.5 B
Enterprise Value18.95 B18.88 B12.44 B17.16 B17.59 B16.21 B
Free Cash Flow184.48 M(204.01 M)262.74 M632.59 M(311.98 M)(320.19 M)
Invested Capital949.32 M658.26 M701.98 M781.16 M1.12 B977.06 M
Invested Capital Average924.01 M574.03 M685.94 M780.37 M996.57 M879.01 M
Market Capitalization18.89 B19.99 B13.53 B18.81 B19.05 B17.24 B
Tangible Asset Value1.22 B1.91 B2.27 B3.08 B3.23 B3.49 B
Working Capital720.68 M1.13 B1.41 B1.97 B1.73 B1.4 B

Incyte Fundamentals

About Incyte Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Incyte Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incyte Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incyte Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware. Incyte Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1773 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Incyte Corp without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Incyte Corp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Incyte Corp Piotroski F Score and Incyte Corp Valuation analysis. Note that the Incyte Corp information on this page should be used as a complementary analysis to other Incyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Incyte Stock analysis

When running Incyte Corp price analysis, check to measure Incyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte Corp is operating at the current time. Most of Incyte Corp's value examination focuses on studying past and present price action to predict the probability of Incyte Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Incyte Corp's price. Additionally, you may evaluate how the addition of Incyte Corp to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Is Incyte Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte Corp. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Incyte Corp is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte Corp's value that differs from its market value or its book value, called intrinsic value, which is Incyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte Corp's market value can be influenced by many factors that don't directly affect Incyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine Incyte Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.